What EA Pharma does

EA Pharma is a French pharmaceutical laboratory, founded in 1948 as Laboratoire Granions and now operating as a subsidiary of the Olyos Group, that manufactures and commercializes oligotherapy medicines, dietary supplements, sports nutrition products, and natural cosmetics. The company's core technology is trace-element-based oligotherapy — a recognized therapeutic discipline — embodied in flagship brands Granions, Oligosol, Oligostim, Rubozinc, and Lithioderm, many of which hold ANSM Marketing Authorizations. Its portfolio also includes the Eafit and Punch Power sports nutrition brands, the Foucaud Paris natural cosmetics line (formulation unchanged since 1946), and category-specific supplements such as Chondrostéo (joint comfort), Veinomix (venous comfort), Duab (urinary comfort), and Conceptio (fertility).

The business model is multi-channel and B2B2C: EA Pharma manufactures under pharmaceutical-grade standards (BPF) across production sites in Haute Savoie, Monaco, and Annemasse, then distributes through 20,000 pharmacies, 500+ parapharmacies, 500 sports stores, and 200 bio stores in France, with international presence across 75 countries via wholly owned subsidiaries (Drasanvi in Spain, Stardea in Italy, W group in the USA) and direct market entries in China (2022) and the USA (2023). Revenue is generated primarily through one-time retail sales of branded products, prescribed or recommended by 6,000+ physicians and supported by athlete ambassador marketing. The company holds N°1 market positions in oligotherapy and pharmacy sports nutrition in France and is the 8th largest player in French dietary supplements, with over 1,000 product references across its portfolio.

Name

EA Pharma

Legal name

COSMO France, Société par Actions Simplifiée

Website

https://ea-pharma.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

101–250 employees

Short description

EA Pharma is a French pharmaceutical laboratory specializing in oligotherapy medicines, dietary supplements, sports nutrition, and natural cosmetics, distributed through 20,000+ French pharmacies and in 75 countries via its Olyos Group subsidiaries.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Dietary Supplements

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Weight Management & Metabolic Supplements (CRADAGAG), Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Oligotherapy medications
• Dietary supplements
• Sports nutrition products
• Trace element formulations
• Natural cosmetics

Headquarters

HQ city

Vallauris

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical products: EA Pharma manufactures and sells oligotherapy medicines (Granions, Oligosol, Oligostim, Rubozinc, Lithioderm) prescribed by physicians for over 50 years. These are distributed through pharmacies.
2. Dietary supplements: The company is the 10th largest dietary supplement laboratory in France, offering products for joint comfort (Chondrostéo), muscle comfort, women's comfort (Duab, Veinomix), weight management (EAFIT minceur active), and fertility (Conceptio).
3. Sports nutrition: EA Pharma is the leader in sports nutrition in pharmacies in France with brands Eafit and Punch Power, offering products from simple foods to complete formulations for athletes and consumers seeking natural or BIO nutrition.
4. Natural cosmetics: The Foucaud Paris brand offers natural cosmetic care products using plant and essential oil benefits.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Core offering

EA Pharma manufactures and commercializes natural health solutions, including oligotherapy medications (Granions, Oligosol, Oligostim, Rubozinc, Lithioderm), dietary supplements (Chondrostéo, Duab, Veinomix, Conceptio), sports nutrition products (Eafit, Punch Power), and natural cosmetics (Foucaud Paris). Products are developed under pharmaceutical-grade manufacturing standards and are distributed through pharmacies, parapharmacies, sports stores, and bio stores to address therapeutic, wellness, and athletic performance needs.

Product overview

EA Pharma is a French pharmaceutical company specializing in oligotherapy and sports nutrition since 1948. The company operates a multi-brand portfolio within the Olyos Group, which encompasses 4 entities (EA Pharma-France, Drasanvi-Spain, Stardea-Italy, W group-USA) and 5 global brands (Laboratoire des Granions, Labcatal, Eafit, Drasanvi, Stardea). Their product portfolio includes: oligotherapy medications (Granions, Oligosol, Oligostim, Rubozinc, Lithioderm) for trace element supplementation; dietary supplements for joint comfort (Chondrostéo), venous health (Veinomix), urinary comfort (Duab), fertility (Conceptio), and slimming (EAFIT Minceur Active); sports nutrition products (Eafit, Punch Power); and natural cosmetics (Foucaud Paris). Products are distributed through 20,000 pharmacies and parapharmacies, 500 sports stores, and 200 bio stores in France, reaching 75 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Laboratoire des Granions: Expert in oligotherapy and trace elements since 1948, prescribed by more than 6000 doctors in France
• Labcatal
• Eafit
• Punch Power
• Duab
• Foucaud Paris
• Drasanvi
• Stardea
• Chondrostéo
• Veinomix
• Conceptio

Products and services

• Granions (Laboratoire des Granions) Brand and laboratory for trace element and oligotherapy medications (Granions, Oligosol, Oligostim, Rubozinc, Lithioderm), prescribed by physicians for over 50 years and available in 18,000 pharmacies in France.
• Labcatal Laboratory and brand for catalytic oligotherapy medications (Oligosol, Rubozinc, Lithioderm), focusing on general medicine and dermatology, distributed in 18,000 pharmacies.
• Eafit Sports nutrition and weight management brand, leader in pharmacy and parapharmacy sports nutrition in France, offering products for athletes and consumers seeking natural or BIO nutrition.
• Punch Power Organic sports nutrition brand offering products for athletes and consumers seeking natural nutrition.
• Foucaud Paris Natural cosmetics brand using essential oils and plant-based ingredients, with a formula unchanged for over 70 years.
• Chondrostéo Joint comfort dietary supplement, leader in articular comfort in France.
• Veinomix Venous/leg comfort supplement for women.
• Conceptio Fertility support dietary supplement.
• EAFIT Minceur Active Slimming and weight management dietary supplement product.
• Oligosol Oligotherapy medication for trace element supplementation, present in 18,000 pharmacies in France.
• Oligostim Oligotherapy medication for trace element supplementation.
• Duab Brand specializing in urinary comfort dietary supplements.

Quantifiable outcome

• Leader in oligotherapy and sports nutrition in French pharmacies
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Newron PharmaceuticalscoreStrategic or Co-development Partner · 20 March 2026EA Pharma has existing development and commercialization agreements with Newron Pharmaceuticals for Japan and Asian territories. The agreement covers evenamide, Newron's novel glutamate modulator for treatment-resistant schizophrenia. EA Pharma handles development and commercialization activities in these regions.
• Myung In PharmminorStrategic or Co-development PartnerNewron Pharmaceuticals has a separate agreement with Myung In Pharm for South Korea. This is mentioned in context of Newron's global partnership network but EA Pharma is not directly party to this agreement.

Scale indicators12 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Naturactive (Pierre Fabre Health Care): French natural health brand under Pierre Fabre specializing in plant-based supplements and aromatherapy distributed via pharmacies. Comparable in natural supplement formats and pharmacy channel focus.
• Arkopharma: French leader in phytotherapy and natural health products distributed through pharmacies. Direct competitor in natural supplements and herbal-based health products across similar therapeutic categories.
• Nutergia: French dietary supplement and micronutrition laboratory serving French pharmacies with a comparable health professional and consumer positioning. Direct overlap in supplement formats and physician-recommended categories.
• Boiron: French global leader in homeopathic medicines with deep pharmacy distribution and physician prescription base. Closely comparable to EA Pharma's oligotherapy medicine franchise (Granions, Oligosol) given the regulatory and channel overlap.
• PiLeJe Micronutrition: French health professional-focused micronutrition brand distributed via pharmacies and practitioners. Direct overlap in physician-prescribed dietary supplements and trace element categories.
• Solgar: Global premium vitamins and dietary supplements brand with strong pharmacy and health food store distribution. Comparable in premium positioning, dietary supplement formats, and natural ingredient focus.
• Pileje (Laboratoire Pileje): French micronutrition and oligotherapy laboratory distributing through French pharmacies with a comparable physician-recommended supplement portfolio. Direct competitor in trace-element therapy and dietary supplements.

Emerging players

• Myprotein: UK-based sports nutrition and supplement brand with strong direct-to-consumer and digital-native distribution. Comparable in sports nutrition product formats but operates via different channel than EA Pharma's pharmacy-led model.

Broad incumbents

• Merck Medication Familiale: French consumer health division of Merck with a broader OTC and supplement portfolio. Larger incumbent with overlapping pharmacy presence but wider therapeutic and product breadth than EA Pharma.
• Bayer Consumer Health: Global consumer health major with broad supplement and self-medication portfolio including pharmacy-distributed brands. Larger incumbent serving overlapping channels and categories with greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/eapharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries7 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EA Pharma